Oncolytics Biotech Inc.

ONCY | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.77

$0 (0.00%)

At close: Sep 21, 2026, 4:00 PM ET

$0.78

+$0.01 (+1.30%)

Pre-market: Sep 22, 2026, 9:18 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Aug 11, 2026

11.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $76.91M

1D Range

0.76 0.79

52W Range

0.73 1.51

Valuation (TTM)

PE -3.13

PB -12.47

EV/EBITDA -1.92

Valuation (NTM)

Forward PE N/A

Forward PEG 0.14

Price Target $5

Cash Flow

FCF Yield -22.1%

SBC Adj. FCF Yield -26.8%

SBC Impact -21.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 6.1% | 10.0%

FCF 3Y | 5Y 5.9% | 3.2%

Returns

ROA -498.1%

ROE 1020.2%

ROIC -1480.5%

Financial Health

Net Cash

C$4.12M

Current Ratio 1.35

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenous...

Sector Healthcare

Industry Biotechnology

Employees 29

IPO Date Oct 4, 2001

Website www.oncolyticsbiotech.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+549.35%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞